|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.90 SEK | -1.54% |
|
+3.57% | - |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-16 | Affärsvärlden Issues Buy Recommendation for Salix | FW |
| 1 day | -1.54% | ||
| 1 week | +3.57% |
| 1 week | 62 |  | 66.6 |
| 1 month | 54.46 | | 66.9 |
| Current year | 54.46 | | 66.9 |
| 1 year | 54.46 | | 66.9 |
| 3 years | 54.46 | | 66.9 |
| 5 years | 54.46 | | 66.9 |
| 10 years | 54.46 | | 66.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Hansson
CEO | Chief Executive Officer | 51 | 2021-08-31 |
Carolina Nerman
DFI | Director of Finance/CFO | 46 | 2023-12-31 |
Christos Selman
PRN | Corporate Officer/Principal | 35 | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 2024-12-31 | |
Andreas Stenbäck
BRD | Director/Board Member | 47 | 2019-01-31 |
| Director/Board Member | 58 | 2025-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-14 | Others | Director | 716,433 | - | ||
| 06-14 | Others | Executive/Senior Manager | 4,000 | - | ||
| 06-14 | Others | Chairman | 18,581,509 | - |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.59B 372M 325M 299M 279M 528M 35.42B 536M 1.39B 17.41B 1.4B 1.37B 60B | 4.12B 427M 373M 343M 319M 606M 40.62B 615M 1.6B 19.97B 1.6B 1.57B 68.81B |
| Net income | 90M 9.33M 8.16M 7.5M 6.99M 13.25M 888M 13.45M 34.99M 437M 35.03M 34.27M 1.5B | 190M 19.7M 17.22M 15.83M 14.75M 27.98M 1.88B 28.4M 73.86M 922M 73.94M 72.36M 3.18B |
| Net Debt | - | - |
Employees
650
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | SEK 63.90 | -1.54% | 54,669 |
| 26-07-02 | SEK 64.90 | +0.78% | 41,504 |
| 26-07-01 | SEK 64.40 | +0.78% | 18,671 |
| 26-06-30 | SEK 63.90 | +2.57% | 24,137 |
| 26-06-29 | SEK 62.30 | +0.97% | 143,044 |
- Stock Market
- Stocks
- SALIX Stock
Select your edition
All financial news and data tailored to specific country editions
